Evidence map›Paper›PMID 19101503›Full record

ArticleBiochemical and biophysical research communications2009

Phosphorylation of cyclin-dependent kinase 2 peptides enhances metal binding.

Graham S Baldwin

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Graham S BaldwinDepartment of Surgery, The University of Melbourne, Austin Health, Studley Road, Heidelberg, Vic, Australia. grahamsb@unimelb.edu.au
Austin Health · AU

Funding

The biology of gastrin-ferric ion complexesR01GM065926 · NIGMS · UNIVERSITY OF MELBOURNE · PI BALDWIN, GRAHAM S · 2002 to 2009
$1.0M
NIGMS NIH HHS 5R01GM065926-05NIGMS NIH HHS R01 GM065926
6 · The paper itself

Abstract

The cyclin-dependent kinase CDK2 is inactivated by phosphorylation on either of the two neighbouring residues Thr14 or Tyr15. The effect of phosphorylation on metal ion binding has been investigated with peptides incorporating residues 6-20 of CDK2. The stoichiometry of Ca(2+) binding increased from 1 in the un- and singly-phosphorylated peptides to 2 in the doubly phosphorylated peptide, without large changes in the affinity (75-250 microM). In contrast although binding of ferric ions to the un-phosphorylated peptide was not detected, both singly- and doubly-phosphorylated peptides bound two Fe(3+) ions. Binding of Ca(2+) or Zn(2+) ions to the doubly phosphorylated CDK2 peptide did not cause any change in absorbance, but increased the affinity of the peptide for Fe(3+) ions. These results demonstrate that double phosphorylation of CDK2 peptides increases the stoichiometry of metal ion binding, and hence may contribute to the previously observed regulation of CDK2 activity by metal ions.

Indexed as

Amino Acid SequenceCalciumCationsCyclin-Dependent Kinase 2HumansIronMetalsMolecular Sequence DataPeptidesPhosphorylationProtein BindingZincCalciumCationsCyclin-Dependent Kinase 2IronMetalsPeptidesZinc

Identifiers

PMID19101503
PMCPMC2680380
OpenAlexW2006286232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.